(Reuters) – Thirteen babies in Brazil born with normal head circumference have been diagnosed with congenital Zika syndrome, with brain scans showing extensive malformations, inflammation and reduced brain volume, researchers reported on Tuesday. Of the 13 infants, 11 gradually developed the birth defect microcephaly, or abnormally small head size, in the months following birth.
(CNN) – The world has watched in wonder as technologists unveil bionic arms and robotic legs. But just as these prosthetic advances offer hope to those who’ve lost limbs, the surgical side of amputations has largely stayed the same, a pioneering doctor said Monday. Not anymore. A first-of-its-kind amputation procedure, conducted in July, was shared during a news conference at Brigham and Women’s Faulkner Hospital in Boston.
(Reuters) – Palliative care may offer a better quality of life to chronically sick or terminally ill patients even if it doesn’t help them live longer, a research review suggests. Research to date on the impact of palliative care has produced mixed results. Some studies have shown a survival benefit but findings have often been muddled by the possibility that there are differences between patients who choose palliative care and those who opt for other types of treatment.
(The Wall Street Journal) – Pope Francis on Monday indefinitely extended the power of priests to forgive the “grave sin” of abortion, one of his signature gestures from the Catholic Church’s just-ended Jubilee Year of Mercy. The pope’s move, which allows priests to forgive women who have had abortions and any other people involved in the process, is largely symbolic. The power to forgive penitents for abortion is formally reserved for bishops, but many bishops around the world have already conceded that power to their priests.
(Vox) – So far, the debate in America has been mainly between positions 1 and 2. Either physician-assisted suicide should be universally forbidden, or it ought to be made available only to the terminally ill. In contrast, I think the debate should be between positions 1 and 3: Physician-assisted suicide ought to be universally forbidden, or universally permitted for competent adults. Both those positions, I contend, embody reasonable — although opposing — viewpoints, and I will not try to decide between them here. But I will argue that position 2, the one adopted by several states, is morally untenable.
(The Sun) – SCIENTISTS believe they are on the brink of a cure for people born deaf after producing stem cells to correct a hereditary defect. Experts have found a way of growing new cells for the cochlea, the spiral cavity of the inner ear. These can be used to replace faulty ones in people deaf from birth due to a genetic error. They hope a treatment could be available to patients within five to 10 years.
(Science Daily) – Scientists report in Nature Medicine using human pluripotent stem cells to grow human intestinal tissues that have functioning nerves in a laboratory, and then using these to recreate and study a severe intestinal nerve disorder called Hirschsprung’s disease. Published online Nov. 21, the findings describe an unprecedented approach to engineer and study tissues in the intestine — the body’s largest immune organ, its food processor and main interface with the outside world.
(The Australian) – An Australian fertility specialist who runs an IVF and surrogacy business in Cambodia has been arrested and charged in Phnom Pen following the announcement of the country’s ban on the commercial surrogacy industry. Tammy Davis-Charles has been arrested and detained by anti-trafficking police for allegedly running an illegal surrogacy service in Cambodia, and will face court tomorrow on charges of engaging in surrogacy and allegedly falsifying documents such as birth certificates.
(Managed Care Magazine) – The world’s first malaria vaccine will be rolled out in pilot projects in sub-Saharan Africa, the World Health Organization (WHO) has announced. Funding is now secured for the initial phase of the program, and vaccinations are due to begin in 2018. The vaccine, known as RTS,S, acts against Plasmodium falciparum, the most deadly malaria parasite globally, and the most prevalent in Africa. Advanced clinical trials have shown RTS,S to provide partial protection against malaria in young children.
(MIT Technology Review) – Scientific advisers to President Obama warn that the U.S. urgently needs a new biodefense strategy and should regularly brief President-elect Donald Trump on the dangers posed by new technologies like CRISPR, gene therapy, and synthetic DNA, which they say could be coöpted by terrorists. In a letter to the president, the President’s Council of Advisors on Science and Technology (PCAST) urges the creation of a new entity charged with developing a national biodefense strategy within six months.
(CNN) – The Zika virus outbreak and related clusters of microcephaly are no longer a public health emergency of international concern, the World Health Organization said Friday. This ends the declaration made by the organization in February due to the simultaneous spread of the virus and “extraordinary clusters” of microcephaly among babies born in areas where the virus was spreading.
(The Conversation) – Medical tourism for assisted reproductive technologies raises a host of legal and ethical questions. While new reproductive technologies, like mitochondrial replacement, promise to bring significant benefits, the absence of regulations means that some of these questions, including those related to safety and risks are unanswered, even as people are starting to use them.
(Quartz) – So are we on the brink of a brave new world of genetically enhanced humanity? Perhaps. And there’s an interesting wrinkle: It’s reasonable to believe that any seismic shift toward genetic enhancement will not be centered in Western countries like the US or the UK, where many modern technologies are pioneered. Instead, genetic enhancement is more likely to emerge out of China.
(Physorg) – A skin-like biomedical technology that uses a mesh of conducting nanowires and a thin layer of elastic polymer might bring new electronic bandages that monitor biosignals for medical applications and provide therapeutic stimulation through the skin. The biomedical device mimics the human skin’s elastic properties and sensory capabilities.
Employment Opportunity: Lecturer in Health Ethics, Law, and Professionalism Opportunity at Deakin University
The Lecturer in Health Ethics, Law and Professionalism will be required to teach, undertake research and publish in the areas of health ethics and/or health law, and professionalism. The appointee will promote the School and establish and maintain links and partnerships with relevant academic, industry and professional communities. The appointee will make an independent contribution to the School’s teaching, research, and program development.
- Teaching in the areas of health ethics and/or health law and professionalism at the undergraduate and postgraduate level that is consistent with the University’s principles of teaching, learning and the student experience.
- Developing learning environments that are flexible, student-centred and accessible, utilising appropriate technology.
- Contributing to building an active (national) research record, including publication and the generation of external research income.
- Participating with colleagues in developing and maintaining links and partnerships with industry and the wider community.
- Undertaking appropriate administrative tasks.
RESEARCH AND SCHOLARSHIP
- Demonstrating evidence of up-to-date knowledge of developments in health ethics and/or health law, and professionalism, and incorporating such developments into learning and teaching practice within the School of Medicine.
- Conducting research and scholarly publication in health ethics and/or health law, and professionalism.
- Contributing to the School and Faculty’s research activity and national profile.
- Engaging in collaborative research projects with colleagues and postgraduate students in one of the School/Faculty’s areas of research strength.
- Supporting local and international student recruitment strategies.
- Participating in the development and maintenance of links and partnerships with industry and relevant professional bodies and the community.
- Providing support to casual teaching staff and collaborating with colleagues in the areas of teaching, research and/or professional activities relevant to health ethics and/or health law, and professionalism.
- Performing administrative tasks commensurate with position responsibilities and contributing to processes that enable the effective operation of the School.
- Contributing to organisational capacity building by participating in and facilitating development of programs relevant to evaluation and self-review of teaching and learning practice. Participating in a community of practice that supports and continuously up-skills in the use of technological tools.
- Participating in the University’s Performance Planning and Review program.
- Assisting with School, Faculty and University committees and carrying out other duties as directed by the Dean of Medicine or Executive Dean (Health).
LEARNING AND TEACHING
- Making a contribution to the Faculty’s undergraduate and postgraduate teaching programs that is consistent with the University’s Strategic Plan and core commitments, in particular contributing to development of health ethics and/or health law and professionalism teaching and fostering life-long learning skills among medical students.
- Coordinating the ethics, law, professionalism, and communication theme curriculum in two year levels of the medical course, including organisation and oversight of relevant assessment activities.
- Contributing to the teaching of programs within the School of Medicine as directed by the Associate Head of School (T&L) or Dean of Medicine.
- Undertaking teaching related duties consistently with the University’s principles of teaching, learning and the student experience
- Collaborating in curriculum design at Unit and Course levels with regards to health ethics and/or health law, and professionalism.
- Developing, promoting and applying innovative and effective teaching and learning practices and materials that accord with the University’s curriculum design standards.
- Delivering learning experiences and outcomes that are personal, engaging, relevant and challenging, for learners studying on campus, in the Cloud or in a combined mode.
- Supervising honours students and HDR students, ensuring successful and timely completions.
- Advising and supporting the development of students regarding teaching and learning.
ORGANISATIONAL CONTEXT AND RELATIONSHIPS
The appointee will form part of the teaching team within the School of Medicine, which is one of five Schools in the Faculty of Health. Staff within the School report to the Executive Dean (Health) through the Dean of Medicine.
The appointee will be actively involved in teaching, research, consulting, industry partnerships, and professional activity. The appointee will interact with other staff within the School and the Faculty, their peers in other universities, both nationally and internationally, and with community, professional and industry organisations. The appointee will liaise with students at all levels.
The position is located at the Geelong Waurn Ponds campus
The University may require an academic staff member who is offered a continuing or fixed term appointment with the University to serve a probationary period of up to 36 months.
ESSENTIAL SELECTION CRITERIA
Qualifications: PhD in a relevant field.
Experience, Knowledge and Skills:
- Demonstrated ability to contribute effectively to the Faculty’s undergraduate and postgraduate teaching programs in a manner that influences, motivates, and inspires students to learn.
- Demonstrated ability to develop and administer assessment regimes and provide feedback that fosters independent learning.
- Experience in teaching and supervision in health ethics and/or health law and/or professionalism at undergraduate or postgraduate levels.
- Experience in developing curricula and educational resources that reflect an understanding of the practical application of ethical or legal principles in the context of healthcare service delivery.
- Knowledge of multi-literacies and experience in teaching effectively in a technology-enhanced contemporary higher education environment.
- Capacity to supervise research students in health ethics and/or health law and/or professionalism.
- Capacity to attract funding for research activities.
- Proven research activity in health ethics and/or health law, including a sound record of publications in highly ranked academic journals.
- Ability to contribute to the development and maintenance of partnerships with professional associations and the health and tertiary education sectors and with domestic educational institutions and industry.
- Demonstrated commitment to Equal Opportunity principles and practices, and Occupational Health and Safety.
- Interpersonal skills that demonstrate the ability to establish and maintain effective working relationships with students, the staff of the Faculty and School and with other members of the University.
- Commitment to the University’s Mission, Core Commitments and Values which include – excellence, academic freedom, collegiality, continuous improvement, ethical behaviour, accountability and environmental responsibility.
DESIRABLE SELECTION CRITERIA
- Current or recent (within last five years) practitioner in a health profession recognized by AHPRA or practical experience in the health care sector.
- Have completed the Graduate Certificate of Higher Education Learning and Teaching (GCHELT) or equivalent. Experience, Knowledge and Skills
- Administration of academic programs, such as course or unit coordination.
- Attracted research funding or consultancy income in the area of health ethics and/or health law.
- Participation in relevant committees and/or board structures.
- Demonstrated personal quality of leadership.
- Flexibility in adjusting to work requirements.
Annual performance objectives and expected outcomes will be defined for this role in accordance with the Minimum Standards and Typical Duties for Academic Levels (MSTDALs) and Faculty Research Expectation Models (FREMs). Specific duties will be allocated with reference to the applicable Workload Allocation Model (WAM). These documents are updated from time to time and are available on request.
HOW TO APPLY
Please apply online via:
Include cover letter, curriculum vitae and a response to the Selection Criteria.
Please quote reference number: 160619
SUPPORT FOR YOUR APPLICATION
All enquiries will be confidential and should be directed to:
Dr Dominique Martin
Senior Lecturer in Health Ethics and Professionalism
Telephone +61 3 5247 9482
CLOSING DATE FOR APPLICATIONS
Sunday4 December 2016
Short-listed candidates will be interviewed by a panel. Details of professional referees will be requested prior to the interview.
REMUNERATION AND BENEFITS
An attractive remuneration package is offered. This will include:
Salary $90,779 – $107,553 per annum pro rata
TERM OF APPOINTMENT
.8 EFT and continuing
(The Guardian) – Last-line antibiotics against serious pneumonia and bloodstream infections are under real threat in Europe as resistant strains of bacteria emerge, experts are warning. A new report from the European Centre for Disease Prevention and Control (ECDC) reveals that resistance has continued to increase across Europe in spite of attempts to raise global awareness of the danger to the fundamentally important antibiotic class of drugs. Without them, some infectious diseases could become untreatable and some forms of major surgery would again become perilous.
(Kaiser Health News) – Victims of “Dr. Death” had until this week to submit receipts for unnecessary chemotherapy, medical bills for liver damage and funeral expenses for their loved ones. By an initial count on Tuesday, 517 former patients and their families had filed claims against Farid Fata, the Detroit-area cancer doctor convicted of raking in over $17 million by poisoning patients with chemotherapy and other drugs they did not need. Fata was branded by prosecutors as “the most egregious fraudster” in U.S. history for scamming Medicare and private insurers by giving at least 553 patients, some of whom did not have cancer, thousands of doses of unnecessary and expensive drugs.
(The Telegraph) – Scientists have condemned the decision of a court to grant permission for a teenage girl to freeze her body after death, claiming the chances of her being revived are ‘infinitesimal.’ Experts said cryogenic companies were irresponsible for implying there is a realistic hope that a dead human could be unfrozen, brought back to life and cured of a fatal disease in the future. They said the High Court had made ‘no assessment of the plausibility of the science’ and warned the ruling could encourage vulnerable people to pursue unrealistic hopes.
(STAT News) – In hopes of reducing inappropriate opioid prescribing, the Chicago City Council on Wednesday passed an ordinance that requires all pharmaceutical sales reps to become licensed. The ordinance, which the pharmaceutical industry opposed, will require sales reps to undergo training for ethics, marketing regulations, and applicable laws. Reps will also have to file reports with the city that disclose the names of doctors they visit as part of their work, the number of visits, and any samples, materials, or gifts provided, along with their value. Reps will also have to pay a $750 licensing fee and renew the licenses annually.
(Washington Post) – An attempt to legalize voluntary euthanasia in an Australian state was defeated by a single vote in parliament on Thursday. The South Australian Parliament rejected the bill on Thursday 24 votes to 23, after a heated overnight debate. South Australia almost became the only Australian state or territory to allow assisted suicide.